Cargando…

Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team

PURPOSE: Whether the coronavirus disease 2019 (COVID-19) pandemic had any effect on the time between blood culture collection and administration of antibiotics in the outpatient Department of Emergency Medicine in a single university hospital in Japan was investigated, and the intervention carried o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Sanae, Sasano, Hiroshi, Suzuki, Mai, Fukui, Yukiko, Chonan, Masayoshi, Kawakami, Takaaki, Tabe, Yoko, Miida, Takashi, Kimura, Toshimi, Naito, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460591/
https://www.ncbi.nlm.nih.gov/pubmed/37641628
http://dx.doi.org/10.2147/IJGM.S418558
_version_ 1785097669191925760
author Kubota, Sanae
Sasano, Hiroshi
Suzuki, Mai
Fukui, Yukiko
Chonan, Masayoshi
Kawakami, Takaaki
Tabe, Yoko
Miida, Takashi
Kimura, Toshimi
Naito, Toshio
author_facet Kubota, Sanae
Sasano, Hiroshi
Suzuki, Mai
Fukui, Yukiko
Chonan, Masayoshi
Kawakami, Takaaki
Tabe, Yoko
Miida, Takashi
Kimura, Toshimi
Naito, Toshio
author_sort Kubota, Sanae
collection PubMed
description PURPOSE: Whether the coronavirus disease 2019 (COVID-19) pandemic had any effect on the time between blood culture collection and administration of antibiotics in the outpatient Department of Emergency Medicine in a single university hospital in Japan was investigated, and the intervention carried out by the antimicrobial stewardship team (AST) to promote the appropriate use of antibiotics was examined. PATIENTS AND METHODS: The monthly percentage of patients who visited the outpatient Department of Emergency Medicine between January 2019 and December 2021 and received an intravenous antibiotic within 3 hours of blood culture collection was calculated. The AST calculated a quality indicator (QI) based on the results of the investigation and started QI monitoring and hospital feedback. RESULTS: From January 2020 to March 2021 (the third COVID-19 wave), the implementation rate of antibiotic administration within 3 hours after blood culture collection decreased as the COVID-19 pandemic spread, and the implementation rate tended to increase as the number of COVID-19-positive patients decreased. However, when the AST started monitoring and feedback from April 2021, although there was a temporary decline in the early stages of the fifth wave when the scale of infection was large, the implementation rate rose and was maintained by AST intervention. (the fourth and the fifth COVID-19 waves) (P<0.01). Also, the implementation rate was significantly lower during the COVID-19 pandemic than during the non- pandemic (P<0.05). CONCLUSION: The early COVID-19 pandemic may have affected the delay in time from blood culture collection to antibiotic administration. Later, in recurring COVID-19 pandemics, AST intervention eliminated this problem. When a bacterial infection such as sepsis is suspected, delayed treatment can be prevented by promptly collecting a blood culture, irrespective of concerns about COVID-19 infection. Calculating the QI may promote AST activities and the appropriate use of antibiotics.
format Online
Article
Text
id pubmed-10460591
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104605912023-08-28 Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team Kubota, Sanae Sasano, Hiroshi Suzuki, Mai Fukui, Yukiko Chonan, Masayoshi Kawakami, Takaaki Tabe, Yoko Miida, Takashi Kimura, Toshimi Naito, Toshio Int J Gen Med Original Research PURPOSE: Whether the coronavirus disease 2019 (COVID-19) pandemic had any effect on the time between blood culture collection and administration of antibiotics in the outpatient Department of Emergency Medicine in a single university hospital in Japan was investigated, and the intervention carried out by the antimicrobial stewardship team (AST) to promote the appropriate use of antibiotics was examined. PATIENTS AND METHODS: The monthly percentage of patients who visited the outpatient Department of Emergency Medicine between January 2019 and December 2021 and received an intravenous antibiotic within 3 hours of blood culture collection was calculated. The AST calculated a quality indicator (QI) based on the results of the investigation and started QI monitoring and hospital feedback. RESULTS: From January 2020 to March 2021 (the third COVID-19 wave), the implementation rate of antibiotic administration within 3 hours after blood culture collection decreased as the COVID-19 pandemic spread, and the implementation rate tended to increase as the number of COVID-19-positive patients decreased. However, when the AST started monitoring and feedback from April 2021, although there was a temporary decline in the early stages of the fifth wave when the scale of infection was large, the implementation rate rose and was maintained by AST intervention. (the fourth and the fifth COVID-19 waves) (P<0.01). Also, the implementation rate was significantly lower during the COVID-19 pandemic than during the non- pandemic (P<0.05). CONCLUSION: The early COVID-19 pandemic may have affected the delay in time from blood culture collection to antibiotic administration. Later, in recurring COVID-19 pandemics, AST intervention eliminated this problem. When a bacterial infection such as sepsis is suspected, delayed treatment can be prevented by promptly collecting a blood culture, irrespective of concerns about COVID-19 infection. Calculating the QI may promote AST activities and the appropriate use of antibiotics. Dove 2023-08-23 /pmc/articles/PMC10460591/ /pubmed/37641628 http://dx.doi.org/10.2147/IJGM.S418558 Text en © 2023 Kubota et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kubota, Sanae
Sasano, Hiroshi
Suzuki, Mai
Fukui, Yukiko
Chonan, Masayoshi
Kawakami, Takaaki
Tabe, Yoko
Miida, Takashi
Kimura, Toshimi
Naito, Toshio
Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title_full Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title_fullStr Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title_full_unstemmed Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title_short Impact of the COVID-19 Pandemic on Initiation of Antibiotic Treatment After Performing a Blood Culture and Intervention by the Antimicrobial Stewardship Team
title_sort impact of the covid-19 pandemic on initiation of antibiotic treatment after performing a blood culture and intervention by the antimicrobial stewardship team
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460591/
https://www.ncbi.nlm.nih.gov/pubmed/37641628
http://dx.doi.org/10.2147/IJGM.S418558
work_keys_str_mv AT kubotasanae impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT sasanohiroshi impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT suzukimai impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT fukuiyukiko impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT chonanmasayoshi impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT kawakamitakaaki impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT tabeyoko impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT miidatakashi impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT kimuratoshimi impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam
AT naitotoshio impactofthecovid19pandemiconinitiationofantibiotictreatmentafterperformingabloodcultureandinterventionbytheantimicrobialstewardshipteam